Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 13, 2026, 1:12 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1873–1896 of 13,940 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Control Trial Clear all

Conditions: Low-risk Papillary Thyroid Cancer, Endocrine Malignancy, Thyroid Cancer
Interventions: Total Thyroidectomy (TT), Prophylactic central neck lymph node dissection (pCND); Procedure
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years and older
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Vaccines, Meningococcal Vaccines
Interventions: rLP2086 and Gardasil, rLP2086, Gardasil; Biological
Lead sponsor: Pfizer; Industry
Eligibility: 11 Years to 17 Years
Enrollment: 2,499 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2013
U.S. locations: 87
States / cities: Daphne, Alabama • Chandler, Arizona • Jonesboro, Arkansas + 57 more

Conditions: Healthy Volunteers
Interventions: GSBR-1290, Placebo; Drug · Other
Lead sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023
U.S. locations: 1
States / cities: Anaheim, California

Conditions: Metabolism and Nutrition Disorder, Obesity
Interventions: NNC 0070-0002-0453, '2-0453, placebo; Drug
Lead sponsor: Novo Nordisk A/S; Industry
Eligibility: 18 Years to 64 Years
Enrollment: 117 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Evansville, Indiana

Conditions: Osteoarthritis, Knee
Interventions: Naproxen, Placebo; Drug
Lead sponsor: Analgesic Solutions; Industry
Eligibility: 21 Years and older
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Natick, Massachusetts

Conditions: Breast Cancer, Heart Disease, Cardiotoxicity, Myocardial Dysfunction
Interventions: Atorvastatin, Placebo; Drug
Lead sponsor: Cedars-Sinai Medical Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Inflammatory Bowel Disease, Ulcerative Colitis
Interventions: UC Home Automated Telemanagement, Best Available Care; Other
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 18 Years and older
Enrollment: 47 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 2
States / cities: Baltimore, Maryland

Conditions: Obesity Complicating Childbirth, Fetal Anomaly
Interventions: traxi® Panniculus Retractor; Device
Lead sponsor: Prisma Health-Upstate; Other
Eligibility: 16 Years and older · Female only
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023
U.S. locations: 1
States / cities: Greenville, South Carolina

Conditions: Migraine Disorders
Interventions: ALD403, Placebo; Biological
Lead sponsor: Alder Biopharmaceuticals, Inc.; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 665 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 82
States / cities: Huntsville, Alabama • Mobile, Alabama • Phoenix, Arizona + 75 more

Conditions: Asthma
Interventions: JNJ-95597528, Placebo; Drug
Lead sponsor: Janssen Research & Development, LLC; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 440 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 7
States / cities: Westminster, California • Boston, Massachusetts • Minneapolis, Minnesota + 4 more

Conditions: Healthy Volunteers
Interventions: immediate release guanfacine hydrochloride, moxifloxacin, Placebo; Drug
Lead sponsor: Shire; Industry
Eligibility: 18 Years to 45 Years
Enrollment: 83 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008
U.S. locations: 1
States / cities: Tacoma, Washington

Conditions: Hepatic Encephalopathy, Cirrhosis, Portosystemic Encephalopathy, PSE
Interventions: Polyethylene glycol 3350-electrolyte solution (GoLYTELY®), Lactulose; Drug
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years to 80 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Preeclampsia, Pregnancy Related
Interventions: Aspirin 81Mg Ec Tab, Aspirin 162Mg Ec Tab; Drug
Lead sponsor: University of Virginia; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Chronic Rhinosinusitis With Nasal Polyps
Interventions: Itepekimab (SAR440340), Placebo, Mometasone furoate nasal spray (MFNS); Drug
Lead sponsor: Sanofi; Industry
Eligibility: 18 Years and older
Enrollment: 231 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 21
States / cities: Arcadia, California • Los Angeles, California • Newport Beach, California + 16 more

Conditions: Pregnancy, Substance Use, Depression, Anxiety
Interventions: Listening to Women and Pregnant and Postpartum People; Behavioral
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years to 41 Years · Female only
Enrollment: 415 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Laryngeal Cleft, Dysphagia
Interventions: Endoscopic suture repair, Injection laryngoplasty; Procedure
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 12 Months to 10 Years
Enrollment: 128 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 2
States / cities: Portland, Oregon • Nashville, Tennessee

Conditions: Depression, Major Depressive Disorder, Dysthymic Disorder, Depressive Symptoms, Type 2 Diabetes, PreDiabetes, Insulin Resistance
Interventions: Good Days Ahead (GDA), Problem Solving Treatment in Primary Care (PST-PC), Antidepressant Medications, Active Control; Behavioral · Drug · Other
Lead sponsor: Indiana University; Other
Eligibility: 18 Years and older
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Amenorrhea
Interventions: r-metHuLeptin, Oral Contraceptive Pills (OCPs), Placebo; Drug · Other
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 18 Years to 35 Years · Female only
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2016
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Gastrointestinal Cancer, Head and Neck Cancer, Dihydropyrimidine Dehydrogenase Deficiency, UGT1A1 Gene Mutation, Breast Cancer
Interventions: Availability of clinical decision support based on pharmacogenomic results.; Other
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years and older
Enrollment: 860 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2028
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Stroke, Stroke, Acute, Balance; Distorted, Balance; Impairment, Gait, Unsteady
Interventions: Body weight support system control group, Body weight support system with balance perturbations; Device
Lead sponsor: Gaylord Hospital, Inc; Other
Eligibility: 18 Years and older
Enrollment: 114 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 4
States / cities: Wallingford, Connecticut • Washington D.C., District of Columbia • Sandwich, Massachusetts + 1 more

Conditions: Down Syndrome
Interventions: Sargramostim for Injection, Saline Placebo; Drug
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 35 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Hypertension in Pregnancy, Preeclampsia, Gestational Hypertension
Interventions: Social incentives-based program; Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older · Female only
Enrollment: 128 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Colonic Neoplasms
Interventions: Normal (0.9%) saline, HalfLytely; Drug
Lead sponsor: Arya, Vijaypal, M.D., P.C.; Individual
Eligibility: 21 Years to 70 Years
Enrollment: 133 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: Middle Village, New York

Conditions: Maternal-Fetal Relations, Mother-Child Relations, Maternal Behavior
Interventions: Mindfulness-Based Childbirth and Parenting, Non-Mindfulness-Based Childbirth Class; Behavioral
Lead sponsor: Heidemarie Laurent; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 95 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2024
U.S. locations: 2
States / cities: Champaign, Illinois • University Park, Pennsylvania

Search by objective public record fields.

Total Thyroidectomy With and Without Prophylactic Central Neck Lymph Node Dissection in People With Low-risk Papillary Thyroid Cancer

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17

A Study of Multiple Ascending Doses of GSBR-1290 in Japanese and Non-Japanese Healthy Participants

A Two Part Trial Investigating an Anti-obesity Drug in Overweight/Obese Male and Female Healthy Volunteers

Trial of Naproxen to Evaluate Various Methods of Measuring Analgesic Effect in Osteoarthritis Pain of the Knee

STOP Heart Disease in Breast Cancer Survivors Trial

The Home Telemanagement (UC HAT) Trial for Patients With Ulcerative Colitis

Pannus Assistance Needed for Obstetric Ultrasound Studies

A Multicenter Assessment of ALD403 in Chronic Migraine

A Study of JNJ-95597528 in Participants With Inadequately Controlled Moderate to Severe Asthma

Guanfacine Immediate-release Electrocardiogram Results (QTc) Study

Efficacy Study of Polyethylene Glycol 3350-electrolyte Solution (GoLYTELY®) Versus Lactulose in Patients With Hepatic Encephalopathy.

Low Dose Aspirin for Preterm Preeclampsia Preventionmg/day Dose in High-risk Patients

A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps

Pilot Randomized Controlled Trial (RCT): Remote SBIRT Vs. In-Person SBIRT

Injection Versus Suture Repair of Laryngeal Clefts

eIMPACT-DM Pilot Trial: Depression Treatment to Reduce Diabetes Risk

Study of Leptin for the Treatment of Hypothalamic Amenorrhea

The PhOCus Trial: Implementation of Pharmacogenomic Testing in Oncology Care

A Multisite Exploration of Balance Perturbations With and Without Body Weight Support

Trial to Evaluate Safety and Efficacy of GM-CSF /Sargramostim in Down Syndrome

Randomized Clinical Trial to Increase Physical Activity After a a Hypertensive Pregnancy

Yoga and Bolus Lukewarm Saline as Rapid Colonoscopy Preparation

Neurobehavioral Effects of Prenatal Mindfulness Training on Maternal Presence and Compassionate Love